Invesco Biotechnology & Genome ETF
PBE
PBE
60 hedge funds and large institutions have $55M invested in Invesco Biotechnology & Genome ETF in 2017 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 18 increasing their positions, 13 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
Holders
60
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.15M | |
| 2 | +$327K | |
| 3 | +$281K | |
| 4 |
Jane Street
New York
|
+$256K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$237K |
Top Sellers
| 1 | -$3.43M | |
| 2 | -$225K | |
| 3 | -$219K | |
| 4 |
VF
Virtu Financial
New York
|
-$93.7K |
| 5 |
AG
Advisor Group
Phoenix,
Arizona
|
-$78.3K |